The occurrence of auditory dysfunction in children with TB receiving ototoxic medication at a TB hospital in South Africa

International Journal of Pediatric Otorhinolaryngology

Volumn 79, Issue 7, 2015, Pages 1101-1105

  Ghafari, Nazanin ^a   Rogers, Christine ^a   Petersen, Lucretia ^a   Singh, Shajila A ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Children; Hearing loss; Monitoring; Ototoxicity; TB

Indexed keywords

AMIKACIN; CAPREOMYCIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ACOUSTIC IMPEDANCE; ADOLESCENT; ARTICLE; AUDIOMETRY; AUDITORY THRESHOLD; CERUMEN IMPACTION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; EARDRUM PERFORATION; FEMALE; HEARING IMPAIRMENT; HIGH FREQUENCY HEARING LOSS; HOSPITALIZATION; HUMAN; INFANT; MALE; MIDDLE EAR DISEASE; MIXED HEARING LOSS; OTOSCOPY; OTOTOXICITY; PERCEPTION DEAFNESS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SOUTH AFRICA; TUBERCULOSIS; CHEMICALLY INDUCED; CLINICAL TRIAL; HEARING LOSS, CONDUCTIVE; HEARING LOSS, MIXED CONDUCTIVE-SENSORINEURAL; HEARING LOSS, SENSORINEURAL;

ADOLESCENT; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HEARING LOSS, CONDUCTIVE; HEARING LOSS, MIXED CONDUCTIVE-SENSORINEURAL; HEARING LOSS, SENSORINEURAL; HOSPITALIZATION; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; SOUTH AFRICA; TUBERCULOSIS;

EID: 84930537414     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2015.04.040     Document Type: Article

References (30)

1. World Health Organization (WHO), Global Tuberculosis Control, 2011, Retrieved April 2, 2013, from 〈〉. http://www.who.int/tb/publications/global_report/2011/gtbr11_main.pdf.
2. Hesseling A. The TB crisis in children. The 41st Union World Conference on Lung Health 2010, Viewed 5 December 2013 〈http://sciencespeaksblog.org/2010/11/17/the-tb-crisis-in-children/〉.
3. World Health Organization (WHO) Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children 2006, Retrieved August 5, 2010, from 〈http://whqlibdoc.who.int/hq/2006/horntonWHO_HTM_TB_2006.371_eng.pdf〉.
4. Espinal M.A., Kim S.J., Suarez P.G., Kam K.M., Khomenko A.G., Migliori G.B., et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000, 283:2537-2545.
5. Xing G., Chen Z., Cao X. Mitochondrial rRNA and tRNA and hearing function. Cell Res. 2007, 17:227-239.
6. Rizzo T. Hospital-Acquired Infections 2002, Retrieved Jun 1, 2010 from 〈http://www.healthline.com/galecontent/hospital-acquired-infections〉.
7. Copley G.J., Friderichs N.B. An approach to hearing loss in children. S. Afr. Fam. Pract. 2010, 52:34-39.
8. Northern J.L., Downs M.P. Hearing in Children 2002, Lippincott Williams & Wilkins, Philadelphia, PA. fifth ed.
9. Seddon J.A., Thee S., Jacobs K., Ebrahim A., Hesseling A.C., Schaaf H.S. Hearing loss in children treated for multidrugresistant tuberculosis. J. Infect. 2013, 66:320e329.
10. Diefendorf A. Assessment of hearing loss in children. Handbook of Clinical Audiology 2009, 545-563. Lippincott Williams & Wilkins, Philadelphia, PA. sixth ed. J. Katz, L. Medwetsky, R. Burkard, L. Hood (Eds.).
11. Hunter M.F., Kimm L., Cafarelli Dees D., Kennedy C.R., Thornton A.R.D. Feasibility of otoacoustic emission detection followed by ABR as a universal neonatal screening test for hearing impairment. Br. J. Audiol. 1994, 28:47-51.
12. Duggal P., Sarkar M. Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up. BMC Ear. Nose Throat Disord. 2007, 7. 7-5.
13. Hardin J.W., Hilbe J.M. Generalized Linear Models and Extensions 2007, Stata Corp LP, College Station, TX. second ed.
14. Peloquin C.A., Berning S.E., Nitta A.T., Simone P.M., Goble M., Huitt G.A., et al. Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases. Clin. Infect. Dis. 2004, 38:1538-1544.
15. De Jager P., Van Altena R. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis. Int. J. Tuberc. Lung Dis. 2002, 6:622-627.
16. Sturdy A., Goodman A., Jose R.J., Loyse A., Donoghue M., Kon O.M., et al. Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice. J. Antimicrob. Chemother. 2011, 66:1815-1820.
17. Lima M.L.L.T., Lessa F., Aguiar-Santos A.M., Medeiros Z. Hearing impairment in patients with tuberculosis from northeast Brazil. Rev. Inst. Med. Trop. Sao Paulo 2006, 48:99-102.
18. Probst R. Pediatric hearing disorders: pediatric audiology. Basic Otorhinolaryngology: A Step-by-Step Learning Guide 2006, 197-207. Thieme, New York, NY. R. Probst, G. Grevers, H. Iro (Eds.).
19. Knight K. Hearing loss in pediatric cancer survivors treated with cisplatin. Oncol. Nurse Ed. 2008, 22:35-37.
20. American Speech-Language Hearing Association (ASHA) Effects of Hearing Loss on Development 2010, American Speech-Language Hearing Association (ASHA), Retrieved Jun 15, 2010 from 〈http://www.readingrockets.org/article/5135〉.
21. Johnson C.D., Benson P.V., Seaton J.B. Educationa Audiology Handbook 1997, Delmar, San Diego, CA.
22. Adams J.W., Rohring P.S. Handbook to Service the Deaf and Hard of Hearing 2004, Elsevier Academic Press, San Diego, CA.
23. Rall E. Psychosocial development of children with hearing loss. ASHA Leader 2007, 17:8-11.
24. Nelson C.H. A neurobiological perspective on early human deprivation. Child Dev. Perspect. 2007, 1:13-18.
25. Ruben R.J. Host susceptibility to sequelae. Evidence-Based Otitis Media 2003, 505-514. BC Decker, Hamilton, Canada. R.M. Rosenfeld, C.D. Bluestone (Eds.).
26. Okur E., Yildirim I., Akif Kilic M., Guzelsoy S. Prevalence of otitis media with effusion among primary school children in Kahramanmaras, in Turkey. Int. J. Pediatr. Otorhinolaryngol. 2004, 68:557-562.
27. Cober M.P., Johnson C.E. Otitis media: review of the 2004 treatment guidelines. Ann. Pharmacother. 2005, 39:1879-1887.
28. Adhikari P. Pattern of ear diseases in rural school children: experiences of free health camps in Nepal. Int. J. Pediatr. Otorhinolaryngol. 2009, 73:1278-1280.
29. Minja B.M., Machemba A. Prevalence of otitis media, hearing impairment and cerumen impaction among school children in rural and urban Dar es Salaam, Tanzania. Int. J. Pediatr. Otorhinolaryngol. 1996, 37:29-34.
30. American Speech-Language-Hearing Association (ASHA) Audiologic Management of Individuals Receiving Cochleotoxic Drug Therapy 1994, American Speech-Language-Hearing Association (ASHA), Retrieved Aug 25, 2009, from 〈http://www.asha.org/docs/html/GL1994-00003.html〉.